Dr. Beckwith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3188 Bellevue Ave
Cincinnati, OH 45219Phone+1 513-475-8500Fax+1 513-584-8554
Education & Training
Ohio State University College of MedicineClass of 2014
Certifications & Licensure
OH State Medical License 2018 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 20 citationsOSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cellsTa-Ming Liu, Yonghua Ling, Jennifer A. Woyach, Kyle A. Beckwith, Yuh Ying Yeh
Blood. 2015-01-08 - 611 citationsIbrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.Jason A. Dubovsky, Kyle A. Beckwith, Gayathri Natarajan, Jennifer A. Woyach, Samantha Jaglowski
Blood. 2013-10-10 - 48 citationsCharacterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease.Erin Hertlein, Kyle A. Beckwith, Gerard Lozanski, Timothy L. Chen, William H. Towns
Plos One. 2013-10-09
Press Mentions
Three Founding Trustees Retire from PVCH Foundation BoardMay 27th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
